Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
CRIS
Stock Latest News
Company Announcements
Curis Announces PIPE Financing and Strategic Capital Strengthening
4d ago
8K
CRIS
Premium
The Fly
Curis announces $80.8M private placement
4d ago
CRIS
Premium
Ratings
Curis’s Promising Clinical Developments and Strategic Trials Justify Buy Rating
1M ago
CRIS
Premium
The Fly
Curis provides updated data from its frontline AML triplet study
1M ago
CRIS
Premium
Ratings
Promising Early Data from Curis’s Emavusertib Study Supports Buy Rating
1M ago
CRIS
Premium
Ratings
Curis’s Strategic Clinical Advancements and Promising Data Drive Buy Rating
2M ago
CRIS
Premium
Company Announcements
Curis Inc. Earnings Call: Clinical Progress and Financial Gains
2M ago
CRIS
Premium
Company Announcements
Curis Inc. Advances Cancer Trials with Promising Results
2M ago
CRIS
Premium
Company Announcements
Curis Completes Sale of Erivedge Business
2M ago
8K
CRIS
Premium
The Fly
Curis reports Q3 EPS (49c), consensus (60c)
2M ago
CRIS
Premium
The Fly
Curis sees cash and cash equivalents sufficient into 1Q26
2M ago
CRIS
Premium
Pre-Earnings
CRIS Earnings this Week: How Will it Perform?
2M ago
CRIS
Premium
Company Announcements
Curis Inc.’s Promising Study on Emavusertib for AML and MDS: A Potential Game-Changer
3M ago
CRIS
Premium
Company Announcements
Curis Inc. Advances Lymphoma Treatment with Emavusertib Study
3M ago
CRIS
Premium
Company Announcements
Curis Granted Nasdaq Compliance Extension Until November
3M ago
8K
CRIS
Premium
Company Announcements
Curis Appeals Nasdaq Delisting Notice After Non-Compliance
5M ago
8K
CRIS
Premium
The Fly
Curis files to sell 4.62M shares of common stock for holders
5M ago
CRIS
Premium
Company Announcements
Curis Files Prospectus Supplement for Stock Offering
5M ago
8K
CRIS
Premium
Ratings
Curis Inc. Receives Buy Rating Amid Promising Clinical Developments and Strong Financial Position
5M ago
CRIS
Premium
Company Announcements
Curis, Inc. Reports Q2 2025 Financial and Clinical Progress
5M ago
CRIS
Premium
Company Announcements
Curis Inc. Earnings Call: Progress Amid Challenges
5M ago
CRIS
Premium
Ratings
Curis Inc: Promising Financial Performance and Clinical Advancements Justify Buy Rating
5M ago
CRIS
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
